Development and Characterization of an Enzymatic Method for the Rapid Determination of Gamma Hydroxybutyric Acid

Development and Characterization of an Enzymatic Method for the Rapid Determination of Gamma Hydroxybutyric Acid

Gamma hydroxybutyric acid (GHB) is a regulated therapeutic drug, which naturally occurs in mammalian brain tissues as an intermediate of the GABA (gamma aminobutyric acid) neurotransmitter metabolism. The increasing misuse of GHB as a narcotic or abusing drug in recent years calls for the...

Full description

Bibliographic Details
Main Authors:	Michel A. Sciotti, Lara Hasan, André Scholer, Thomas M. Jermann, Jakob M. Weber, Daniel Gygaxa
Format:	Article
Language:	deu
Published:	Swiss Chemical Society 2010-11-01
Series:	CHIMIA
Subjects:	Enzymatic assay Gamma hydroxybutyric acid Ghb Ghb dehydrogenase Reaction mechanism
Online Access:	https://www.chimia.ch/chimia/article/view/4924

Similar Items

Gamma-Hydroxybutyrate (GHB) Withdrawal
by: Everett, Worth W
Published: (2001-04-01)

Gamma-hydroxybutyrate (GHB) and Gamma-butyrolactone (GBL): Analysis of overdose cases reported to the Swiss Toxicological Information Centre
by: Swiss Medical Weekly
Published: (2004-09-01)

Gamma-hydroxybutyrate (GHB): A New Generation of Drugs from the Chemical Shelf
by: Peter X. Iten, et al.
Published: (2002-03-01)

Characterization of the GHB Withdrawal Syndrome
by: Casper J. H. Wolf, et al.
Published: (2021-05-01)

A Comparison Study of Impulsiveness, Cognitive Function, and P300 Components Between Gamma-Hydroxybutyrate and Heroin-Addicted Patients: Preliminary Findings
by: Tingting Zeng, et al.
Published: (2022-04-01)

Gamma-hydroxybutyric acid-induced organic delirium complicated by polydrug use successfully treated with electroconvulsive therapy: a case report
by: Mads F. Kjærgaard, et al.
Published: (2021-12-01)

Bifunctionalized Gold Nanoparticles for the Colorimetric Detection of the Drug γ-Hydroxybutyric Acid (GHB) in Beverages
by: Silvia Rodríguez-Nuévalos, et al.
Published: (2021-06-01)

Study of Gamma-Hydroxybutyric Acid (GHB) Concentrations in Postmortem Blood and Urine
by: Huda M Hassan, et al.
Published: (2015-12-01)

An Overview of the Putative Structural and Functional Properties of the GHBh1 Receptor through a Bioinformatics Approach
by: Casper J. H. Wolf, et al.
Published: (2023-03-01)

Toxicological screening in the Amsterdam acute setting becomes more relevant if the standard panel of the drugs-of-abuse point-of-care test is expanded with GHB and ketamine
by: J.A.J. van der Schaar, et al.
Published: (2020-01-01)

Prevention of Lipotoxicity in Pancreatic Islets with Gammahydroxybutyrate
by: Justin Hou Ming Yung, et al.
Published: (2022-02-01)

Towards Extending the Detection Window of Gamma-Hydroxybutyric Acid—An Untargeted Metabolomics Study in Serum and Urine Following Controlled Administration in Healthy Men
by: Andrea E. Steuer, et al.
Published: (2021-03-01)

Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management
by: Marinelli Enrico, et al.
Published: (2020-03-01)

Suppression by gamma-hydroxybutyric acid of alcohol deprivation effect in rats: Preclinical evidence of its anti-relapse properties
by: Giancarlo eColombo, et al.
Published: (2012-11-01)

Complications in post-mortem GHB cut-off values in urine samples: A case report
by: N.H.C. Loos, et al.
Published: (2023-01-01)

Toxicological Characterization of GHB as a Performance-Enhancing Drug
by: Arianna Giorgetti, et al.
Published: (2022-04-01)

Toxicokinetic/Toxicodynamic Interaction Studies in Rats between the Drugs of Abuse γ-Hydroxybutyric Acid and Ketamine and Treatment Strategies for Overdose
by: Nisha V. Kwatra, et al.
Published: (2021-05-01)

Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Determination of Endogenous GHB and GHB-Glucuronide in Nails
by: Francesco Paolo Busardò, et al.
Published: (2018-10-01)

GHB: a life-threatening drug complications and outcome of GHB detoxification treatment—an observational clinical study
by: Peter Neu, et al.
Published: (2023-10-01)

Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate
by: Tomi eSarkanen, et al.
Published: (2014-08-01)

Targeted screening of succinic semialdehyde dehydrogenase deficiency (SSADHD) employing an enzymatic assay for γ-hydroxybutyric acid (GHB) in biofluids
by: C. Wernli, et al.
Published: (2017-06-01)

Novel biomarkers and age-related metabolite correlations in plasma and dried blood spots from patients with succinic semialdehyde dehydrogenase deficiency
by: Trevor Kirby, et al.
Published: (2020-09-01)

CaMKIIα as a Promising Drug Target for Ischemic Grey Matter
by: Nane Griem-Krey, et al.
Published: (2022-11-01)

Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses
by: Desiree Madah-Amiri, et al.
Published: (2017-09-01)

Cellular and molecular outcomes of glutamine supplementation in the brain of succinic semialdehyde dehydrogenase‐deficient mice
by: Madalyn N. Brown, et al.
Published: (2020-11-01)

Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine
by: Henry H. C. Lee, et al.
Published: (2022-02-01)

La soumission chimique par GHB dans les milieux festifs nocturnes : qu’est-ce que c’est ?
by: Vanessa Morais Da Rocha, et al.
Published: (2023-09-01)

Assessment of genetically modified cotton GHB614 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA–GMO–RX–018)
by: EFSA Panel on Genetically Modified Organisms (GMO), et al.
Published: (2021-07-01)

The Molecular Mechanism of <i>GhbHLH121</i> in Response to Iron Deficiency in Cotton Seedlings
by: Jie Li, et al.
Published: (2023-05-01)

Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency
by: Malaspina Patrizia, et al.
Published: (2009-01-01)

POISONING WITH GAMMA-HYDROXYBUTYRATE, GAMMA-BUTYROLACTONE AND 1.4-BUTANDIOL
by: Miran Brvar, et al.
Published: (2002-09-01)

Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System
by: Paolo Frisoni, et al.
Published: (2023-08-01)

Anti-alcohol and anxiolytic properties of a new chemical entity, GET73
by: Antonella eLoche, et al.
Published: (2012-02-01)

Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse
by: Tay E, et al.
Published: (2022-02-01)

Intoxicaciones delictivas
by: Ariana Cerón-Apipilhuasco, et al.
Published: (2023-07-01)

Editorial: Psychiatric and Pharmacotoxicological Insights on Appearance and Performance Enhancing Drugs
by: Simona Zaami, et al.
Published: (2022-05-01)

Assessment of genetically modified cotton GHB811 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐ES‐2018‐154)
by: EFSA Panel on Genetically Modified Organisms (GMO), et al.
Published: (2021-08-01)

Temporal differences in gamma-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: a retrospective study
by: Boyd James J, et al.
Published: (2012-02-01)

Sex and Cross-Sex Testosterone Treatment Alters Gamma-Hydroxybutyrate Acid Toxicokinetics and Toxicodynamics in Rats
by: Qing Zhang, et al.
Published: (2024-01-01)

Metabolic Disorders in Delirious Syndrome in Patients with Acute Poisoning with Gamma-Hydroxybutyric Acid and its Precursor
by: A. G. Sinenchenko, et al.
Published: (2020-10-01)